What guides MHC-restricted TCR recognition?

被引:36
|
作者
Mazza, Catherine
Malissen, Bernard
机构
[1] Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France
[2] INSERM, U631, F-13288 Marseille 9, France
[3] CNRS, UMR6102, F-13288 Marseille 9, France
基金
澳大利亚研究理事会;
关键词
T cell; TCR; MHC; evolution; CD4/CD8;
D O I
10.1016/j.smim.2007.03.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC-encoded molecules govern adaptive immune responses by presenting peptides to T cell receptors (TCRs). Based on TCR-MHC crystal structures, we revisit the extent of TCR binding degeneracy, a property with important biological consequences because the diversity of TCR ligands that can be encountered exceeds the number of T cell clones present in a person at any one time. We also discuss whether the approximate diagonal binding of TCR on MHC molecules is due to an intrinsic property of the TCR variable regions, or results from the action of the CD4 and CD8 coreceptors during intrathymic T cell selection. Finally, we discuss how MHC restriction of antigen recognition might have emerged during evolution. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:225 / 235
页数:11
相关论文
共 50 条
  • [41] Self-peptide/MHC and TCR antagonism: Physiological role and therapeutic potential
    Vukmanovic, S
    Santori, FR
    CELLULAR IMMUNOLOGY, 2005, 233 (02) : 75 - 84
  • [42] Conserved biophysical compatibility among the highly variable germline-encoded regions shapes TCR-MHC interactions
    Boughter, Christopher T.
    Meier-Schellersheim, Martin
    ELIFE, 2023, 12
  • [43] MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+T cells exhibit multifunctional effector and helper responses, in vitro
    Ray, Swagatam
    Chhabra, Arvind
    Chakraborty, Nitya G.
    Hegde, Upendra
    Dorsky, David I.
    Chodon, Thinle
    von Euw, Erika
    Comin-Anduix, Begonya
    Koya, Richard C.
    Ribas, Antoni
    Economou, James S.
    Rosenberg, Steven A.
    Mukherji, Bijay
    CLINICAL IMMUNOLOGY, 2010, 136 (03) : 338 - 347
  • [44] Collaboration of TCR-, CD4- and CD28-mediated signalling in antigen-specific MHC class II-restricted T-cells
    Gogolak, P
    Rethy, B
    Horvath, A
    Toth, GK
    Cervenak, L
    Laszlo, G
    Rajnavolgyi, E
    IMMUNOLOGY LETTERS, 1996, 54 (2-3) : 135 - 144
  • [45] Cross- and Alloreactivity, MHC Restriction: Lessons from TCR-pMHC Structures
    Housset, D.
    Reiser, J. -B.
    Darnault, C.
    Gregoire, C.
    Mosser, T.
    Guimezanes, A.
    Schmitt-Verhulst, A. -M.
    Fontecilla-Camps, J. C.
    Mazza, G.
    Malissen, B.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C498 - C498
  • [46] Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules
    Bethune, Michael T.
    Li, Xiao-Hua
    Yu, Jiaji
    McLaughlin, Jami
    Cheng, Donghui
    Mathis, Colleen
    Moreno, Blanca Homet
    Woods, Katherine
    Knights, Ashley J.
    Garcia-Diaz, Angel
    Wong, Stephanie
    Hu-Lieskovan, Siwen
    Puig-Saus, Cristina
    Cebon, Jonathan
    Ribas, Antoni
    Yang, Lili
    Witte, Owen N.
    Baltimore, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (45) : E10702 - E10711
  • [47] Characterization of the interaction of a TCR α chain variable domain with MHC II I-A molecules
    Qadri, A
    Thatte, J
    Radu, CG
    Ober, B
    Ward, ES
    INTERNATIONAL IMMUNOLOGY, 1999, 11 (06) : 967 - 977
  • [48] EFFECTS OF MHC-II CONFORMATION AND PH ON THE RECOGNITION OF PEPTIDE BY T-CELLS
    BANGIA, N
    GHUMMAN, B
    WATTS, TH
    MOLECULAR IMMUNOLOGY, 1994, 31 (17) : 1303 - 1312
  • [49] Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
    Minh Ngoc Duong
    Erdes, Efe
    Hebeisen, Michael
    Rufer, Nathalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [50] Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors
    Deng, Lu
    Mariuzza, Roy A.
    SEMINARS IN IMMUNOLOGY, 2006, 18 (03) : 159 - 166